Annual report
4528.TEDINET S100TMQ7
Period2023-04-01 → 2024-03-31
Filed2024-06-21
StandardIFRS
ConsolidatedYes
Data checks21 of 21 passed
Key figures · 157
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥502.7bn | 2023-04-01 → 2024-03-31 | Cons. | Revenue IFRS |
| Revenue | ¥447.2bn | 2022-04-01 → 2023-03-31 | Cons. | Revenue IFRS |
| Revenue | ¥361.4bn | 2021-04-01 → 2022-03-31d | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥309.3bn | 2020-04-01 → 2021-03-31d | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥292.4bn | 2019-04-01 → 2020-03-31d | Cons. | Revenue IFRS (5-year summary) |
| Operating income | ¥159.9bn | 2023-04-01 → 2024-03-31 | Cons. | Operating profit loss IFRS |
| Operating income | ¥142.0bn | 2022-04-01 → 2023-03-31 | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥163.7bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥143.5bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥105.0bn | 2021-04-01 → 2022-03-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥100.9bn | 2020-04-01 → 2021-03-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥79.7bn | 2019-04-01 → 2020-03-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Net income (owners) | ¥128.0bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥112.7bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥80.5bn | 2021-04-01 → 2022-03-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥75.4bn | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥59.7bn | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income | ¥128.0bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss IFRS |
| Net income | ¥112.9bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss IFRS |
| Total assets | ¥913.7bn | at 2024-03-31 | Cons. | Assets IFRS |
| Total assets | ¥882.4bn | at 2023-03-31 | Cons. | Assets IFRS |
| Total assets | ¥739.2bn | at 2022-03-31d | Cons. | Total assets IFRS (5-year summary) |
| Total assets | ¥745.4bn | at 2021-03-31d | Cons. | Total assets IFRS (5-year summary) |
| Total assets | ¥673.4bn | at 2020-03-31d | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥115.1bn | at 2024-03-31 | Cons. | Liabilities IFRS |
| Total liabilities | ¥134.6bn | at 2023-03-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥798.6bn | at 2024-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥747.8bn | at 2023-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥661.7bn | at 2022-03-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥793.0bn | at 2024-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥741.9bn | at 2023-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥655.9bn | at 2022-03-31d | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Equity (owners) | ¥634.1bn | at 2021-03-31d | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Equity (owners) | ¥562.5bn | at 2020-03-31d | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥166.1bn | at 2024-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥96.1bn | at 2023-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥69.1bn | at 2022-03-31d | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥61.0bn | at 2021-03-31d | Cons. | Cash and cash equivalents IFRS (5-year summary) |
| Cash & equivalents | ¥69.0bn | at 2020-03-31d | Cons. | Cash and cash equivalents IFRS (5-year summary) |
| Operating cash flow | ¥110.7bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥159.6bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥61.8bn | 2021-04-01 → 2022-03-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥74.0bn | 2020-04-01 → 2021-03-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥74.2bn | 2019-04-01 → 2020-03-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Investing cash flow | ¥48.1bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥100.3bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | ¥6.0bn | 2021-04-01 → 2022-03-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥57.6bn | 2020-04-01 → 2021-03-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥10.2bn | 2019-04-01 → 2020-03-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Financing cash flow | −¥89.8bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥32.5bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥60.2bn | 2021-04-01 → 2022-03-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥24.8bn | 2020-04-01 → 2021-03-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥54.7bn | 2019-04-01 → 2020-03-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| EPS (basic) | ¥266.61 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥230.85 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥162.19 | 2021-04-01 → 2022-03-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥151.11 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥118.47 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥266.57 | 2023-04-01 → 2024-03-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥230.79 | 2022-04-01 → 2023-03-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥162.16 | 2021-04-01 → 2022-03-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥151.09 | 2020-04-01 → 2021-03-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥118.45 | 2019-04-01 → 2020-03-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| Net assets per share | ¥1,688.43 | at 2024-03-31 | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥1,519.19 | at 2023-03-31 | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥1,343.4 | at 2022-03-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥1,270.45 | at 2021-03-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥1,126.95 | at 2020-03-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Equity ratio | 86.8% | at 2024-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 84.1% | at 2023-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 88.7% | at 2022-03-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 85.1% | at 2021-03-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 83.5% | at 2020-03-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| ROE | 16.7% | 2023-04-01 → 2024-03-31 | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 16.1% | 2022-04-01 → 2023-03-31 | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 12.5% | 2021-04-01 → 2022-03-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 12.6% | 2020-04-01 → 2021-03-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 10.7% | 2019-04-01 → 2020-03-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| Employees | 3,853 | at 2024-03-31 | Cons. | Number of employees |
| Employees | 3,761 | at 2023-03-31 | Cons. | Number of employees |
| Employees | 3,687 | at 2022-03-31d | Cons. | Number of employees |
| Employees | 3,607 | at 2021-03-31d | Cons. | Number of employees |
| Employees | 3,560 | at 2020-03-31d | Cons. | Number of employees |
| Revenue | ¥498.8bn | 2023-04-01 → 2024-03-31 | Standalone | Net sales |
| Revenue | ¥441.2bn | 2022-04-01 → 2023-03-31 | Standalone | Net sales |
| Revenue | ¥357.0bn | 2021-04-01 → 2022-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥305.2bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥286.2bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥187.9bn | 2023-04-01 → 2024-03-31 | Standalone | Operating income |
| Operating income | ¥152.0bn | 2022-04-01 → 2023-03-31 | Standalone | Operating income |
| Ordinary income | ¥188.0bn | 2023-04-01 → 2024-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥150.8bn | 2022-04-01 → 2023-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥121.1bn | 2021-04-01 → 2022-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥86.8bn | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥70.8bn | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥198.0bn | 2023-04-01 → 2024-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥148.2bn | 2022-04-01 → 2023-03-31 | Standalone | Income before income taxes |
| Net income | ¥152.9bn | 2023-04-01 → 2024-03-31 | Standalone | Profit loss |
| Net income | ¥117.2bn | 2022-04-01 → 2023-03-31 | Standalone | Profit loss |
| Net income | ¥94.6bn | 2021-04-01 → 2022-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥76.9bn | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥69.3bn | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥847.3bn | at 2024-03-31 | Standalone | Assets |
| Total assets | ¥804.6bn | at 2023-03-31 | Standalone | Assets |
| Total assets | ¥661.9bn | at 2022-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥669.6bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥599.4bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥97.1bn | at 2024-03-31 | Standalone | Liabilities |
| Total liabilities | ¥119.0bn | at 2023-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥750.2bn | at 2024-03-31 | Standalone | Net assets |
| Net assets / equity | ¥685.6bn | at 2023-03-31 | Standalone | Net assets |
| Net assets / equity | ¥599.2bn | at 2022-03-31d | Standalone | Net assets |
| Net assets / equity | ¥574.6bn | at 2021-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥507.7bn | at 2020-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥184.8bn | at 2024-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥147.0bn | at 2023-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥318.51 | 2023-04-01 → 2024-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥239.96 | 2022-04-01 → 2023-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥190.51 | 2021-04-01 → 2022-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥154.1 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥137.59 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥318.49 | 2023-04-01 → 2024-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥239.94 | 2022-04-01 → 2023-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥190.49 | 2021-04-01 → 2022-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥154.08 | 2020-04-01 → 2021-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥137.57 | 2019-04-01 → 2020-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥80 | 2023-04-01 → 2024-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥70 | 2022-04-01 → 2023-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥56 | 2021-04-01 → 2022-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥50 | 2020-04-01 → 2021-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥45 | 2019-04-01 → 2020-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥1,597.16 | at 2024-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,403.84 | at 2023-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,226.79 | at 2022-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,150.68 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,016.83 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 88.5% | at 2024-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 85.2% | at 2023-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 90.5% | at 2022-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 85.8% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 84.7% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 21.3% | 2023-04-01 → 2024-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 18.2% | 2022-04-01 → 2023-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 16.1% | 2021-04-01 → 2022-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 14.2% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 13.7% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 498,692,000 | at 2024-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 517,425,000 | at 2023-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 528,341,000 | at 2022-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 528,341,000 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 528,341,000 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 3,437 | at 2024-03-31 | Standalone | Number of employees |
| Employees | 3,381 | at 2023-03-31 | Standalone | Number of employees |
| Employees | 3,354 | at 2022-03-31d | Standalone | Number of employees |
| Employees | 3,319 | at 2021-03-31d | Standalone | Number of employees |
| Employees | 3,287 | at 2020-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 2
| Segment | Item | Period | Value |
|---|---|---|---|
| Pharmaceutical Productsreportable segment | employees | at 2024-03-31 | 3853 pure |
| Pharmaceutical Productsreportable segment | employees | at 2024-03-31 | 3437 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,933
| Item | Context | Value | Unit |
|---|---|---|---|
| Buildings and structures acquisition cost IFRS | CurrentYearInstant | 125301000000 | JPY |
| Machinery and vehicles acquisition cost IFRS | CurrentYearInstant | 30836000000 | JPY |
| Tools furniture and fixtures acquisition cost IFRS | CurrentYearInstant | 30751000000 | JPY |
| Construction in progress acquisition cost IFRS | CurrentYearInstant | 968000000 | JPY |
| Property plant and equipment acquisition cost IFRS | CurrentYearInstant | 218756000000 | JPY |
| Land accumulated impairment losses IFRS | Prior1YearInstant | -996000000 | JPY |
| Buildings and structures accumulated depreciation and impairment losses IFRS | Prior1YearInstant | -67156000000 | JPY |
| Machinery and vehicles accumulated depreciation and impairment losses IFRS | Prior1YearInstant | -19405000000 | JPY |
| Tools furniture and fixtures accumulated depreciation and impairment losses IFRS | Prior1YearInstant | -19813000000 | JPY |
| Construction in progress accumulated impairment losses IFRS | Prior1YearInstant | － | JPY |
| Property plant and equipment accumulated depreciation and impairment losses IFRS | Prior1YearInstant | -107370000000 | JPY |
| Land accumulated impairment losses IFRS | CurrentYearInstant | -1148000000 | JPY |
| Buildings and structures accumulated depreciation and impairment losses IFRS | CurrentYearInstant | -71721000000 | JPY |
| Machinery and vehicles accumulated depreciation and impairment losses IFRS | CurrentYearInstant | -20407000000 | JPY |
| Tools furniture and fixtures accumulated depreciation and impairment losses IFRS | CurrentYearInstant | -20729000000 | JPY |
| Construction in progress accumulated impairment losses IFRS | CurrentYearInstant | － | JPY |
| Property plant and equipment accumulated depreciation and impairment losses IFRS | CurrentYearInstant | -114004000000 | JPY |
| Land IFRS | Prior1YearInstant | 29960000000 | JPY |
| Buildings and structures IFRS | Prior1YearInstant | 55544000000 | JPY |
| Machinery and vehicles IFRS | Prior1YearInstant | 10869000000 | JPY |
| Tools furniture and fixtures IFRS | Prior1YearInstant | 10548000000 | JPY |
| Construction in progress IFRS | Prior1YearInstant | 1500000000 | JPY |
| Property plant and equipment IFRS | Prior1YearInstant | 108420000000 | JPY |
| Land IFRS | CurrentYearInstant | 29751000000 | JPY |
| Buildings and structures IFRS | CurrentYearInstant | 53580000000 | JPY |
| Machinery and vehicles IFRS | CurrentYearInstant | 10430000000 | JPY |
| Tools furniture and fixtures IFRS | CurrentYearInstant | 10023000000 | JPY |
| Construction in progress IFRS | CurrentYearInstant | 968000000 | JPY |
| Property plant and equipment IFRS | CurrentYearInstant | 104752000000 | JPY |
| Patents and licenses acquisition cost IFRS | Prior1YearInstant | 99220000000 | JPY |
| Software acquisition cost IFRS | Prior1YearInstant | 15454000000 | JPY |
| Other components of intangible assets acquisition cost IFRS | Prior1YearInstant | 1090000000 | JPY |
| Intangible assets acquisition cost IFRS | Prior1YearInstant | 115765000000 | JPY |
| Patents and licenses acquisition cost IFRS | CurrentYearInstant | 108775000000 | JPY |
| Software acquisition cost IFRS | CurrentYearInstant | 15986000000 | JPY |
| Other components of intangible assets acquisition cost IFRS | CurrentYearInstant | 1029000000 | JPY |
| Intangible assets acquisition cost IFRS | CurrentYearInstant | 125790000000 | JPY |
| Patents and licenses accumulated amortization and impairment losses IFRS | Prior1YearInstant | -37771000000 | JPY |
| Software accumulated amortization and impairment losses IFRS | Prior1YearInstant | -8464000000 | JPY |
| Other components of intangible assets accumulated amortization and impairment losses IFRS | Prior1YearInstant | -396000000 | JPY |
| Intangible assets accumulated amortization and impairment losses IFRS | Prior1YearInstant | -46631000000 | JPY |
| Patents and licenses accumulated amortization and impairment losses IFRS | CurrentYearInstant | -59030000000 | JPY |
| Software accumulated amortization and impairment losses IFRS | CurrentYearInstant | -9103000000 | JPY |
| Other components of intangible assets accumulated amortization and impairment losses IFRS | CurrentYearInstant | -370000000 | JPY |
| Intangible assets accumulated amortization and impairment losses IFRS | CurrentYearInstant | -68502000000 | JPY |
| Patents and licenses IFRS | Prior1YearInstant | 61449000000 | JPY |
| Software IFRS | Prior1YearInstant | 6990000000 | JPY |
| Other components of intangible assets IFRS | Prior1YearInstant | 695000000 | JPY |
| Intangible assets IFRS | Prior1YearInstant | 69134000000 | JPY |
| Patents and licenses IFRS | CurrentYearInstant | 49746000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 21 of 21 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |